HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J R Berenson Selected Research

Therapeutics

7/2014Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.
1/2005Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma.
4/2001New advances in the biology and treatment of myeloma bone disease.
3/2000American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J R Berenson Research Topics

Disease

12Multiple Myeloma
07/2014 - 05/2000
9Neoplasms (Cancer)
12/2001 - 03/2000
5Hypercalcemia (Milk Alkali Syndrome)
11/2001 - 10/2000
5Neoplasm Metastasis (Metastasis)
04/2001 - 03/2000
5Bone Resorption
04/2001 - 10/2000
3Monoclonal Gammopathy of Undetermined Significance
01/2021 - 09/2000
3Breast Neoplasms (Breast Cancer)
04/2001 - 03/2000
2Pain (Aches)
04/2001 - 03/2000
2Spontaneous Fractures (Pathological Fracture)
04/2001 - 03/2000
2Bone Diseases (Bone Disease)
01/2001 - 10/2000
1Smoldering Multiple Myeloma
01/2021
1Plasma Cell Leukemia
05/2012
1Azotemia
06/2001
1Albuminuria
06/2001
1Postmenopausal Osteoporosis
06/2001
1Acute-Phase Reaction
04/2001
1Epstein-Barr Virus Infections
09/2000
1Chromosome Aberrations (Chromosome Abnormalities)
07/2000
1Cancer Pain
03/2000
1Melanoma (Melanoma, Malignant)
03/2000
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2000
1Spinal Cord Compression
03/2000
1Plasmacytoma
03/2000

Drug/Important Bio-Agent (IBA)

8Zoledronic Acid (Zometa)FDA Link
11/2001 - 10/2000
7Diphosphonates (Bisphosphonates)IBA
11/2001 - 03/2000
6Pamidronate (Aredia)FDA LinkGeneric
06/2001 - 03/2000
3Pharmaceutical PreparationsIBA
06/2001 - 03/2000
3Analgesics (Analgesic Drugs)IBA
04/2001 - 03/2000
3DNA (Deoxyribonucleic Acid)IBA
11/2000 - 05/2000
2Bortezomib (Velcade)FDA Link
07/2014 - 07/2012
2NitrogenIBA
06/2001 - 01/2001
2Biomarkers (Surrogate Marker)IBA
04/2001 - 01/2001
2collagen type I trimeric cross-linked peptideIBA
04/2001 - 01/2001
2CytokinesIBA
10/2000 - 07/2000
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2021
1carfilzomibIBA
07/2014
1Lenalidomide (CC 5013)FDA Link
07/2012
1liposomal doxorubicin (Doxil)FDA Link
07/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2012
11-dodecylpyridoxal (PLD)IBA
07/2012
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
10/2006
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2005
1Melphalan (Alkeran)FDA LinkGeneric
01/2005
1Arsenic Trioxide (Trisenox)FDA Link
01/2005
1NF-kappa B (NF-kB)IBA
12/2001
1deoxypyridinolineIBA
01/2001
1Acetylglucosaminidase (NAGase)IBA
01/2001
1Immunoglobulin G (IgG)IBA
09/2000
1AntigensIBA
09/2000
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2000
1Cyclin-Dependent Kinase Inhibitor p16IBA
03/2000
1pristane (pristan)IBA
03/2000

Therapy/Procedure

4Therapeutics
07/2014 - 03/2000
2Drug Therapy (Chemotherapy)
10/2000 - 03/2000
2Radiotherapy
10/2000 - 03/2000
1Cell Transplantation
05/2012
1Transplantation
05/2000
1Duration of Therapy
03/2000